von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, et al. Soft tissue sarcoma, version 2.2014. J Natl Compr Cancer Netw. 2014;12(4):473–83.
Article
Google Scholar
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
Article
PubMed
Google Scholar
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.
Article
PubMed
Google Scholar
Blay JY, van Glabbeke M, Verweij J, van Oosterom AT, Le Cesne A, Oosterhuis JW, et al. Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy. Eur J Cancer (Oxford, England). 2003;39(1):64–9.
Article
Google Scholar
van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet (London, England). 2012;379(9829):1879–86.
Article
CAS
Google Scholar
Rappoport N, Shamir R. Multi-omic and multi-view clustering algorithms: review and cancer benchmark. Nucleic Acids Res. 2019;47(2):1044.
Article
PubMed
Google Scholar
Liang L, Fang JY, Xu J. Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. Oncogene. 2016;35(12):1475–82.
Article
CAS
PubMed
Google Scholar
Asiedu MK, Thomas CF Jr, Dong J, Schulte SC, Khadka P, Sun Z, et al. Pathways impacted by genomic alterations in pulmonary carcinoid tumors. Clin Cancer Res. 2018;24(7):1691–704.
Article
CAS
PubMed
Google Scholar
Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 2001;61(8):3410–8.
CAS
PubMed
Google Scholar
Cancer Genome Atlas Research Network, Analysis Working Group, Asan U, Agency BCC, Brigham, Women's H, Broad I, et al. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017 541(7636):169–75.
Song Y, Li L, Ou Y, Gao Z, Li E, Li X, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509(7498):91–5.
Article
CAS
PubMed
Google Scholar
Sun Y, Shi N, Lu H, Zhang J, Ma Y, Qiao Y, et al. ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma. Carcinogenesis. 2014;35(9):1941–50.
Article
CAS
PubMed
Google Scholar
Hu L, Wu Y, Guan X, Liang Y, Yao X, Tan D, et al. Germline copy number loss of UGT2B28 and gain of PLEC contribute to increased human esophageal squamous cell carcinoma risk in Southwest China. Am J Cancer Res. 2015;5(10):3056–71.
CAS
PubMed
PubMed Central
Google Scholar
Chen YB, Jia WH. A comprehensive genomic characterization of esophageal squamous cell carcinoma: from prognostic analysis to in vivo assay. Chin J Cancer. 2016;35(1):76.
Article
PubMed
PubMed Central
Google Scholar
Chen Y, Wang D, Peng H, Chen X, Han X, Yu J, et al. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCepsilon-NF-kappaB signaling pathway and VEGF-C/ Bcl-2 expression. Mol Cancer. 2019;18(1):1.
Article
PubMed
PubMed Central
Google Scholar
Lin DC, Wang MR, Koeffler HP. Genomic and epigenomic aberrations in esophageal squamous cell carcinoma and implications for patients. Gastroenterology. 2018;154(2):374–89.
Article
PubMed
Google Scholar
Chang WL, Lai WW, Kuo IY, Lin CY, Lu PJ, Sheu BS, et al. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma. J Gastroenterol. 2017;52(6):705–14.
Article
CAS
PubMed
Google Scholar
Woo HG, Choi JH, Yoon S, Jee BA, Cho EJ, Lee JH, et al. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer. Nat Commun. 2017;8(1):839.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zheng M, Hu Y, Gou R, Wang J, Nie X, Li X, et al. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma. Aging (Albany NY). 2019;11(12):4198–215.
Article
CAS
Google Scholar
Mirzal A. Nonparametric Tikhonov regularized NMF and its application in cancer clustering. IEEE/ACM Trans Comput Biol Bioinform. 2014;11(6):1208–17.
Article
PubMed
Google Scholar
Yu N, Gao YL, Liu JX, Shang J, Zhu R, Dai LY. Co-differential gene selection and clustering based on graph regularized multi-view NMF in cancer genomic data. Genes (Basel). 2018;9(12):586.
Article
CAS
Google Scholar
Ye C, Toyoda K, Ohtsuki T. Blind source separation on non-contact heartbeat detection by non-negative matrix factorization algorithms. IEEE Trans Biomed Eng. 2019;67:482–94.
Article
PubMed
Google Scholar
Shen R, Mo Q, Schultz N, Seshan VE, Olshen AB, Huse J, et al. Integrative subtype discovery in glioblastoma using iCluster. PLoS ONE. 2012;7(4):e35236.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17(1):174.
Article
PubMed
PubMed Central
CAS
Google Scholar
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lazar AJ, McLellan MD, Bailey MH, Miller CA, Appelbaum EL, Cordes MG, Fronick CC, Fulton LA, Fulton RS, Mardis ER, Schmidt HK. Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell. 2017;171(4):950–65.
Article
PubMed Central
CAS
Google Scholar
Orth MF, Gerke JS, Knösel T, Altendorf-Hofmann A, Musa J, Alba-Rubio R, et al. Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma. Int J Cancer. 2019;144(4):859–67.
Article
CAS
PubMed
Google Scholar
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.
Article
CAS
PubMed
Google Scholar
Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458(7239):719–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, et al. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology (Baltimore, MD). 2008;47(2):511–20.
Article
CAS
Google Scholar
Chochi Y, Kawauchi S, Nakao M, Furuya T, Hashimoto K, Oga A, et al. A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study. J Pathol. 2009;217(5):677–84.
Article
CAS
PubMed
Google Scholar
Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Can Res. 2001;61(8):3225–9.
CAS
Google Scholar
Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11):1148–59.
Article
CAS
PubMed
Google Scholar
Mair AR, Woolley J, Martinez M. Cardiovascular effects of intravenous gadolinium administration to anaesthetized dogs undergoing magnetic resonance imaging. Vet Anaesth Analg. 2010;37(4):337–41.
Article
CAS
PubMed
Google Scholar
Tian T, Ruan M, Yang W, Shui R. Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers. Oncotarget. 2016;7(28):44395–405.
Article
PubMed
PubMed Central
Google Scholar
Nguyen N, Bellile E, Thomas D, McHugh J, Rozek L, Virani S, et al. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Head Neck. 2016;38(7):1074–84.
Article
PubMed
PubMed Central
Google Scholar
Brambilla E, Le Teuff G, Marguet S, Lantuejoul S, Dunant A, Graziano S, et al. Prognostic effect of tumor lymphocytic infiltration in resectable non-small-cell lung cancer. J Clin Oncol. 2016;34(11):1223–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960–4.
Article
CAS
PubMed
Google Scholar
Liu K, Yang K, Wu B, Chen H, Chen X, Chen X, et al. Tumor-infiltrating immune cells are associated with prognosis of gastric cancer. Medicine (Baltimore). 2015;94(39):e1631.
Article
CAS
Google Scholar
Chang YS, Wu W, Walsh G, Hong WK, Mao L. Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. Clinical Cancer Res. 2003;9(10 Pt 1):3641–4.
CAS
Google Scholar
Zhang Y, Li M, Liu Y, Han N, Zhang K, Xiao T, et al. ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients. Chin J Lung Cancer. 2010;13(12):1089–93.
CAS
Google Scholar
Takahashi A, Nakayama R, Ishibashi N, Doi A, Ichinohe R, Ikuyo Y, et al. Analysis of gene expression profiles of soft tissue sarcoma using a combination of knowledge-based filtering with integration of multiple statistics. PLoS ONE. 2014;9(9):e106801.
Article
PubMed
PubMed Central
CAS
Google Scholar
Dupuis-Girod S, Bailly S, Plauchu H. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care. J Thromb Haemost. 2010;8(7):1447–56.
Article
CAS
PubMed
Google Scholar
Mitchell D, Pobre EG, Mulivor AW, Grinberg AV, Castonguay R, Monnell TE, et al. ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth. Mol Cancer Ther. 2010;9(2):379–88.
Article
CAS
PubMed
Google Scholar
Cunha SI, Pietras K. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood. 2011;117(26):6999–7006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cunha SI, Pardali E, Thorikay M, Anderberg C, Hawinkels L, Goumans MJ, et al. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J Exp Med. 2010;207(1):85–100.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hernandez-Varas P, Colo GP, Bartolome RA, Paterson A, Medrano-Fernandez I, Arellano-Sanchez N, et al. Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells. J Biol Chem. 2011;286(21):18492–504.
Article
CAS
PubMed
PubMed Central
Google Scholar